Market research
002720.KO Kukje Pharma Co., Ltd
KO KRW Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 76B
- P/E ratio
- 16.2
- Analyst target
- Not available
- Dividend yield
- 0.8%
- Beta
- 0.22
Profile
Company facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- KR7002720001
- Market cap
- 76B
- P/E ratio
- 16.2
- Analyst target
- Not available
- Dividend yield
- 0.8%
- Beta
- 0.22
About
About Kukje Pharma Co., Ltd
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 002720.KO discussion.
5 years, 6 months ago
Kukje Pharma Co., Ltd is currently in a long term downtrend where the price is trading 8.6% below its 200 day moving average.
From a valuation standpoint, the stock is 88.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Kukje Pharma Co., Ltd's total revenue sank by 3.9% to $28B since the same quarter in the previous year.
Its net income has dropped by 594.7% to $-4B since the same quarter in the previous year.
Finally, its free cash flow fell by 246.5% to $-5B since the same quarter in the previous year.
Based on the above factors, Kukje Pharma Co., Ltd gets an overall score of 1/5.